Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Electronic patient self-Reporting of Adverse ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

We conducted a randomized trial involving children with type 1 diabetes who were 6 to 13 years of age to assess the efficacy and safety of this closed-loop system in this age range.

Because of advances in hematopoietic cell transplant (HCT), meeting the long-term health needs of increasing numbers of HCT survivors remains challenging. This multicenter trial aimed to assess the ...

Jie Chen et al. from Sun Yat-Sen Memorial Hospital, of Sun Yat-sen University published a paper entitled "Psychological effects of virtual reality intervention on breast cancer patients with different ...

In this randomized, controlled trial involving patients with very high use of health care services, readmission rates were not lower among patients randomly assigned to the Coalition’s program ...

MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, together with its Taiwanese ...